Kappers, M.H.W.

sunitinib patient hypertension treatment effect receptor study inhibition pressure thyroid inhibitor angiogenesi blood factor angiogenesis inhibition level proteinuria blood pressure sunitinib-induced toxicity increase kinase endothelin administration cell carcinoma change nitric macitentan cancer control oxide dysfunction decrease growth tyrosine mechanism nitric oxide therapy sunitinib treatment function chapter side effects development activation tumor metastatic oxidative stress sunitinib administration hypothyroidism growth factor figure bevacizumab vegfr protein baseline heart carcinoma vehicle van den meiracker response excretion kidney activity disease serum sunitinib withdrawal 8 days system sunitinib-induced hypertension stress endothelin system oncol capillary expression tempol table oxidative thyroid dysfunction tsh levels production